ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,596Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 823

$952K Total Retail Price of All Prescriptions

Rank: 24 out of 823

643 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 643 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 8,168 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NEXIUM 384 267 1 10
ALENDRONATE SODIUM 354 282 2 42
METFORMIN HCL 353 228 3 14
LISINOPRIL 350 263 4 4
LEVOTHYROXINE SODIUM 347 257 5 6
CRESTOR 338 253 6 20
SIMVASTATIN 326 250 7 2
AMLODIPINE BESYLATE 247 211 8 3
METOPROLOL TARTRATE 241 166 9 11
OMEPRAZOLE 204 115 10 5
FUROSEMIDE 190 173 11 7
HYDROCODONE-ACETAMINOPHEN 175 109 S3 12 1
TRAMADOL HCL 175 108 12 15
GLIPIZIDE 172 117 14 105
ZOLPIDEM TARTRATE 167 100 15 17
HYDROCHLOROTHIAZIDE 156 128 16 29
DICLOFENAC SODIUM 156 118 16 174
JANUVIA 151 88 18 70
AZITHROMYCIN 150 94 19 48
LEVOFLOXACIN 147 110 20 101
NAMENDA 138 128 21 28
METOPROLOL SUCCINATE 134 108 22 9
MELOXICAM 134 99 22 27
TAMSULOSIN HCL 123 111 24 21
LOSARTAN POTASSIUM 123 85 24 26
FENOFIBRATE 119 74 26 152
LYRICA 108 71 27 58
DONEPEZIL HCL 107 106 28 24
CLOPIDOGREL 90 65 29 16
TRICOR 89 55 30 150
CIPROFLOXACIN HCL 88 63 31 32
ONGLYZA 87 54 32 275
GABAPENTIN 85 61 33 8
BYSTOLIC 82 54 34 98
ATORVASTATIN CALCIUM 81 67 35 13
INSULIN SYRINGE 79 31 36 125
SERTRALINE HCL 76 45 37 38
EXELON 73 68 38 102
METOCLOPRAMIDE HCL 73 57 38 95
VESICARE 71 58 40 126
WARFARIN SODIUM 70 55 41 18
POTASSIUM CHLORIDE 68 44 42 22
BENICAR HCT 67 54 43 195
FLUOXETINE HCL 67 40 43 84
LANTUS 67 30 43 76
CYMBALTA 66 47 46 40
GLYBURIDE-METFORMIN HCL 66 48 R 46 121
CLONIDINE HCL 65 23 48 41
GLYBURIDE 62 42 R 49 150
DIOVAN HCT 60 46 50 79
PLAVIX 57 48 51 25
MECLIZINE HCL 56 51 52 184
LEVEMIR 56 36 52 270
ESCITALOPRAM OXALATE 54 39 54 99
JANUMET 54 26 54 193
POLYETHYLENE GLYCOL 3350 54 48 54 87
LEVOCETIRIZINE DIHYDROCHLORIDE 54 44 54 347
DIOVAN 53 45 58 35
NOVOLIN R 53 32 58 296
NOVOLOG MIX 70-30 53 35 58 214
DEXILANT 51 44 61 52
PREDNISONE 51 31 61 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.